 |
PDBsum entry 1uoh
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
279:1541-1545
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53.
|
|
S.Krzywda,
A.M.Brzozowski,
H.Higashitsuji,
J.Fujita,
R.Welchman,
S.Dawson,
R.J.Mayer,
A.J.Wilkinson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Gankyrin is a 25-kDa hepatocellular carcinoma-associated protein that mediates
protein-protein interactions in cell cycle control and protein degradation. It
has been reported to form complexes with cyclin-dependent kinase 4,
retinoblastoma protein, the S6b ATPase subunit of the 19 S regulator of the 26 S
proteasome, and Mdm2, an E3 ubiquitin ligase involved in p53 degradation. It is
the first protein described to bind both to the 26 S proteasome and to proteins
in other complexes containing cyclin-dependent kinase(s) and p53 ubiquitylating
activities, thus providing a mechanism for delivering cell cycle regulating
machinery and ubiquitylated substrates to the proteasome for degradation.
Gankyrin contains a 33-residue motif known as the ankyrin repeat that occurs
five and a half to six times in the sequence. As a step toward understanding
gankyrin interactions with its protein partners we have determined its
three-dimensional crystal structure to 2.0-A resolution. It reveals that the
entire 226-residue gankyrin polypeptide folds into seven ankyrin repeat
elements. The ankyrin repeats, consisting of an antiparallel beta-hairpin
followed by a perpendicularly oriented helix-loop-helix, pack side-by-side,
creating an extended curved structure with a groove running across the long
concave surface. Comparison with the structures of other ankyrin repeat proteins
suggests that interactions with partner proteins are mediated by residues
situated on this concave surface.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIG. 1. Structure of gankyrin. A, stereo view of the 2F[o]
- F[c] electron density maps contoured at the 1 level
and displayed on residues 74-78 of ANK2 and 107-111 of ANK3.
B-D, orthogonal ribbon representations of gankyrin. The
polypeptide chain is color-ramped from its N terminus in blue to
the C terminus in red. E, alignment of the five full ankyrin
repeat sequences (ANK1-ANK5) together with sequences at the N
(ANK0) and C (ANK6) termini of the molecule, which in the
structure adopts the ankyrin repeat fold. The schematic below
the alignment indicates the span of the -helical and -strand
segments of the structure. A consensus ankyrin repeat sequence
(16) is shown below the structure. Residues that match the
consensus are in blue. F, van der Waals surface representation
of gankyrin, with residues colored according to side chain
polarity: white, apolar; green, neutral polar; red, acidic;
blue, basic. The view is of the concave surface of the molecule
in the same orientation as in D.
|
 |
Figure 4.
FIG. 4. Conformation of LXCXE motifs. Shown is the HPV E7
peptide bound to the pocket domain of Rb (A) and gankyrin (B).
In A all the Rb protein atoms are colored in pink with the HPV
E7 peptide atoms colored according to element. The Leu, Cys, and
Glu side chains of the E7 peptide are buried by their
interaction with Rb. In B, gankyrin atoms are colored pink
except for those of Leu178, Cys180, and Glu182, which are
colored by element. The Cys180 side chain is buried in the
protein core.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2004,
279,
1541-1545)
copyright 2004.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
P.Iakova,
L.Timchenko,
and
N.A.Timchenko
(2011).
Intracellular signaling and hepatocellular carcinoma.
|
| |
Semin Cancer Biol,
21,
28-34.
|
 |
|
|
|
|
 |
D.Serquera,
W.Lee,
G.Settanni,
P.E.Marszalek,
E.Paci,
and
L.S.Itzhaki
(2010).
Mechanical unfolding of an ankyrin repeat protein.
|
| |
Biophys J,
98,
1294-1301.
|
 |
|
|
|
|
 |
J.H.Man,
B.Liang,
Y.X.Gu,
T.Zhou,
A.L.Li,
T.Li,
B.F.Jin,
B.Bai,
H.Y.Zhang,
W.N.Zhang,
W.H.Li,
W.L.Gong,
H.Y.Li,
and
X.M.Zhang
(2010).
Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells.
|
| |
J Clin Invest,
120,
2829-2841.
|
 |
|
|
|
|
 |
P.Pugach,
A.Krarup,
A.Gettie,
M.Kuroda,
J.Blanchard,
M.Piatak,
J.D.Lifson,
A.Trkola,
and
M.Robbiani
(2010).
In vivo binding and retention of CD4-specific DARPin 57.2 in macaques.
|
| |
PLoS One,
5,
e12455.
|
 |
|
|
|
|
 |
S.Tong,
H.Zhou,
Y.Gao,
Z.Zhu,
X.Zhang,
M.Teng,
and
L.Niu
(2009).
Crystal structure of human osteoclast stimulating factor.
|
| |
Proteins,
75,
245-251.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Y.Kim,
W.Hur,
J.E.Choi,
D.Kim,
J.S.Wang,
H.Y.Yoon,
L.S.Piao,
and
S.K.Yoon
(2009).
Functional characterization of human oncoprotein gankyrin in Zebrafish.
|
| |
Exp Mol Med,
41,
8.
|
 |
|
|
|
|
 |
C.Chen,
C.Huang,
S.Chen,
J.Liang,
W.Lin,
G.Ke,
H.Zhang,
B.Wang,
J.Huang,
Z.Han,
L.Ma,
K.Huo,
X.Yang,
P.Yang,
F.He,
and
T.Tao
(2008).
Subunit-subunit interactions in the human 26S proteasome.
|
| |
Proteomics,
8,
508-520.
|
 |
|
|
|
|
 |
C.M.Ortiz,
T.Ito,
E.Tanaka,
S.Tsunoda,
S.Nagayama,
Y.Sakai,
H.Higashitsuji,
J.Fujita,
and
Y.Shimada
(2008).
Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance.
|
| |
Int J Cancer,
122,
325-332.
|
 |
|
|
|
|
 |
A.Mahajan,
Y.Guo,
C.Yuan,
C.M.Weghorst,
M.D.Tsai,
and
J.Li
(2007).
Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16.
|
| |
J Mol Biol,
373,
990.
|
 |
|
|
|
|
 |
Y.Nakamura,
K.Nakano,
T.Umehara,
M.Kimura,
Y.Hayashizaki,
A.Tanaka,
M.Horikoshi,
B.Padmanabhan,
and
S.Yokoyama
(2007).
Structure of the oncoprotein gankyrin in complex with S6 ATPase of the 26S proteasome.
|
| |
Structure,
15,
179-189.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Nakamura,
T.Umehara,
A.Tanaka,
M.Horikoshi,
B.Padmanabhan,
and
S.Yokoyama
(2007).
Purification, crystallization and preliminary X-ray diffraction analysis of the non-ATPase subunit Nas6 in complex with the ATPase subunit Rpt3 of the 26S proteasome from Saccharomyces cerevisiae.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun,
63,
190-192.
|
 |
|
|
|
|
 |
X.H.Zhang,
C.Zhao,
K.Seleznev,
K.Song,
J.J.Manfredi,
and
Z.A.Ma
(2006).
Disruption of G1-phase phospholipid turnover by inhibition of Ca2+-independent phospholipase A2 induces a p53-dependent cell-cycle arrest in G1 phase.
|
| |
J Cell Sci,
119,
1005-1015.
|
 |
|
|
|
|
 |
D.H.Dreyfus,
M.Nagasawa,
E.W.Gelfand,
and
L.Y.Ghoda
(2005).
Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.
|
| |
BMC Immunol,
6,
12.
|
 |
|
|
|
|
 |
B.A.Manjasetty,
C.Quedenau,
V.Sievert,
K.Büssow,
F.Niesen,
H.Delbrück,
and
U.Heinemann
(2004).
X-ray structure of human gankyrin, the product of a gene linked to hepatocellular carcinoma.
|
| |
Proteins,
55,
214-217.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.Tanaka,
M.Nakanishi,
Y.Kusakabe,
Y.Goto,
Y.Kitade,
and
K.T.Nakamura
(2004).
Structural basis for recognition of 2',5'-linked oligoadenylates by human ribonuclease L.
|
| |
EMBO J,
23,
3929-3938.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |